Skip to main content

Table 2 Observed and predicted maximum values for Google Trends (GT) on five chronic diseases (March 2020)

From: Anomalous asthma and chronic obstructive pulmonary disease Google Trends patterns during the COVID-19 pandemic

 

Asthma

COPD

Diabetes mellitus

Hypertension

Crohn’s disease

Maximum GT observed value (March 2020)

Maximum GT predicted value (March 2020)

Maximum GT observed value (March 2020)

Maximum GT predicted value (March 2020)

Maximum GT observed value (March 2020)

Maximum GT predicted value (March 2020)

Maximum GT observed value (March 2020)

Maximum GT predicted value (March 2020)

Maximum GT observed value (March 2020)

Maximum GT predicted value (March 2020)

Europe

 Austria

67

29

42

37

71

94

45

45

21

26

 Belgium

67

30

21

20

69

88

38

42

25

27

 Bulgaria

27

26

17

14

86

97

78

75

6

17

 Czech Republic

37

35

14

17

63

92

32

34

18

40

 Denmark

87

27

26

31

82

92

13

14

14

14

 Finland

76

34

10

15

67

77

31

27

13

17

 France

100

25

24

12

68

60

51

44

22

31

 Germany

87

30

53

34

68

88

41

44

18

20

 Greece

52

20

27

15

73

93

31

33

13

32

 Hungary

34

18

100

12

37

65

39

47

10

20

 Ireland

100

29

45

28

84

78

49

40

29

28

 Italy

41

29

11

12

78

32

74

67

13

32

 Netherlands

64

21

27

21

60

74

29

37

14

15

 Norway

100

28

11

23

55

70

49

32

14

23

 Poland

28

18

11

8

44

78

24

33

10

12

 Portugal

50

25

9

15

52

70

18

26

15

22

 Romania

18

18

7

9

100

94

42

31

4

11

 Russia

26

29

9

10

61

97

33

41

6

9

 Spain

62

19

15

23

56

61

65

64

13

39

 Sweden

41

14

12

15

41

44

32

20

7

8

 Switzerland

100

26

28

22

56

59

62

34

14

21

 Ukraine

24

25

10

8

75

100

37

47

7

10

 United Kingdom

100

13

35

12

58

42

30

18

12

14

Africa

 Egypt

8

8

3

4

55

86

10

14

69

4

 South Africa

32

20

9

11

60

70

40

44

7

8

North America

 Canada

69

23

31

24

95

100

46

55

18

22

 USA

60

28

28

24

99

100

59

64

16

22

Latin America

 Argentina

21

8

6

8

30

35

30

27

3

19

 Brazil

52

25

11

8

87

96

72

59

8

25

 Chile

49

26

11

17

64

87

64

69

8

10

 Colombia

26

22

35

19

46

62

100

74

3

22

 Ecuador

23

18

7

10

46

63

75

49

9

8

 Mexico

19

19

12

12

76

87

69

67

3

5

 Peru

39

26

5

9

64

87

57

51

4

6

 Venezuela

31

28

5

12

48

63

71

71

3

10

Asia

 Hong Kong

23

33

14

15

69

100

43

63

5

14

 India

22

19

10

10

61

79

31

33

3

4

 Indonesia

53

53

7

10

87

100

83

100

1

2

 Iran

68

82

1

2

16

34

16

16

6

4

 Israel

27

20

9

10

52

98

18

25

19

20

 Japan

51

43

12

8

68

88

26

30

4

9

 Malaysia

35

40

11

13

90

100

59

79

2

5

 Pakistan

30

37

12

18

66

100

55

69

7

7

 Philippines

87

59

20

20

78

100

81

91

5

7

 Saudi Arabia

13

16

2

3

59

83

8

12

46

5

 Singapore

19

20

7

9

47

78

37

81

3

7

 South Korea

17

20

10

12

63

92

27

45

7

11

 Taiwan

24

29

9

12

82

100

45

68

2

5

 Thailand

16

20

10

12

81

100

40

56

3

3

 Turkey

65

34

100

22

60

76

40

30

6

10

 UAE

22

18

6

6

55

73

22

33

6

8

 Vietnam

16

20

9

9

95

88

29

36

1

2

Pacific

 Australia

77

48

28

24

85

94

45

42

17

23

 New Zealand

91

36

39

25

76

100

33

42

19

28

  1. Maximum predicted values correspond to the maximum values of the upper bound of the 95% confidence intervals for predicted asthma GT. Numbers in italic indicate cases in which maximum GT observed values were higher than maximum predicted values
  2. COPD Chronic obstructive pulmonary disease, USA United States of America